Skip to content
Search

Latest Stories

UK competition watchdog to investigate PCR Covid test price

The UK’s competition watchdog said on Thursday (August 12) it would investigate the price of PCR Covid tests ‘immediately’ and help the government in taking action against testing companies if they were found breaching consumer law.

Health Secretary Sajid Javid had written to the Competition and Markets Authority (CMA) on August 6 asking it to look into the market for PCR tests to ensure that consumers did not face unnecessarily high charges or poor service.


The CMA said in a statement that it was exploring if individual PCR providers were breaching their obligations under consumer law, and if there were structural problems in the market for PCR tests that could affect price or reliability.

It would also examine if there was any immediate action that the government could take in the meantime.

George Lusty, CMA Senior Director for Consumer Protection, said: “It is essential that people paying for PCR tests are treated fairly, get what they pay for and that their rights are respected when things go wrong. We will not hesitate to take enforcement action if we find evidence that PCR providers are breaching consumer law.

“We are also working closely with DHSC to get the data we need to identify the cause of any wider problems in the PCR testing market, and to ground our advice on what action may be needed.”

For international travel during the coronavirus pandemic, the UK has divided countries in three categories, with low-risk countries rated green for quarantine-free travel, medium risk countries rated amber, and red countries requiring arrivals to spend 10 days in isolation in a hotel.

Tests cost about £75 per person on average but there are reports of some being offered for as little as £20, and others more than £500.

All travellers from countries on the green and amber lists must book a test to be taken two days after they arrive in Britain.

Earlier, the CMA had said it would respond to Javid’s request “within a month”, which sparked an angry reaction from travel industry and people.

“...we welcome the opportunity to explore issues in the PCR testing market in more depth. We recognise that this is a very live issue, impacting consumer now, so we will tailor our work to allow us to respond within the next month,” CMA Chief Executive Andrea Coscelli CBE said in a letter addressed to the Health Secretary Sajid Javid on August 10.

More For You

Infant formula: Food, diet and obesity committee welcomes CMA proposals, demands action on processed foods
CMA study shows that parents could save around £300 a year by switching to a lower priced infant formula brand (gettyimages)

Infant formula: CMA calls for stronger labelling and advertising rules

All infant formula brands should be displayed together and separately from other formula milks in stores to enable quick and easy price comparisons – suggests CMA 

The Competition and Marketing Authority (CMA) has recommended the governments of the four UK nations to strengthen advertising and labelling rules of infant formula to help parents make informed decisions and save money.

This follows a CMA study on infant formula and follow-on milks, which found that a combination of factors was leading to poor outcomes for parents.

Keep ReadingShow less
David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.

Keep ReadingShow less
Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

Leverage pharmacy skill mix to improve medicines adherence - report suggests

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

The report, How medicines optimisation contributes to population health, published recently by policy institute Public Policy Projects, highlighted that non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed.

Keep ReadingShow less
GHP calls for 10% mandated protected learning time for NHS pharmacists in new campaign
Many pharmacists end up doing ‘unpaid work’ to catch up with the required training (gettyimages)

Increase protected learning time for NHS pharmacists – GHP launches national campaign

Many pharmacists end up doing ‘unpaid work’ to catch up with the required training or completing self-learning in their own time.

The Guild of Healthcare Pharmacists (GHP) has launched a national campaign advocating for pharmacists working in the NHS to have a minimum of 10% of their contracted hours protected for supporting professional activities (SPA).

In a statement published on 7 February 2025, the GHP emphasised that this protected time “should be recognized by employers and embedded in job plans.”

Keep ReadingShow less
Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Kinnock confirms that an announcement on the 2025/26 GP contract would be made before April 2025

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed.

Kinnock made this statement in response to a written question from Nick Timothy, Conservative MP for West Suffolk, who asked the secretary of state for health and social care, if he will review the reimbursement system for pharmacies and GP practices dispensing medicines.

Keep ReadingShow less